Medical condition
Mcrc
Mcrc is a medical condition tracked by NovaPharmaNews across 3 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- fruquintinib (FRUZAQLA) Antineoplastic and immunomodulating agents (L01)
- panitumumab (VECTIBIX) Antineoplastic and immunomodulating agents (L01)
- ramucirumab (CYRAMZA) Antineoplastic and immunomodulating agents (L01)